Chia Tai Tianqing Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHIA TAI TIANQING, and what generic and branded alternatives to CHIA TAI TIANQING drugs are available?
CHIA TAI TIANQING has two approved drugs.
Drugs and US Patents for Chia Tai Tianqing
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chia Tai Tianqing | FULVESTRANT | fulvestrant | SOLUTION;INTRAMUSCULAR | 211422-001 | Feb 7, 2020 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chia Tai Tianqing | FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 212143-001 | Mar 3, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.